Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Inari Medical Inc NARI

Healthcare Medical Devices
Inari Medical, Inc. is a medical device company. The Company’s products primarily consist of ClotTriever and FlowTriever systems, which are catheter-based mechanical thrombectomy systems that are used for the treatment of the venous thromboembolism (VTE) deep vein thrombosis (DVT), and pulmonary embolism (PE). Its InThrill system is used for the removal of emboli and thrombi from the peripheral... see more

Recent & Breaking News (NDAQ:NARI)

INVESTIGATION NOTICE: Kaskela Law LLC Announces Stockholder Investigation of Inari Medical, Inc. (NARI) and Encourages Long-Term NARI Investors to Contact the Firm

Newsfile 4 days ago

Inari Medical, Inc. (NARI) Shareholder Alert: Grabar Law Office Is Investigating Misconduct Claims on Your Behalf

Newsfile 10 days ago

Inari Medical to Participate in the Jefferies London Healthcare Conference

GlobeNewswire November 6, 2024

Notice to Long-Term Inari (NARI) Shareholders: Grabar Law Office Is Investigating Misconduct Claims on Your Behalf

Newsfile November 1, 2024

PEERLESS Results Show Superiority of FlowTriever® Compared to Catheter-Directed Thrombolytics for Intermediate-Risk Pulmonary Embolism

GlobeNewswire October 29, 2024

Inari Medical Reports Third Quarter 2024 Financial Results

GlobeNewswire October 28, 2024

Okami Medical Announces Closing Of $32.5M Financing

PR Newswire October 21, 2024

Attention Long-Term Inari (NARI) Shareholders: Grabar Law Office Is Investigating Misconduct Claims on Your Behalf

Newsfile October 18, 2024

Inari Medical Announces Partnership with AVF and NBCA on DEFIANCE Trial

GlobeNewswire October 15, 2024

SHAREHOLDER ALERT: GRABAR LAW OFFICE IS INVESTIGATING POSSIBLE MISCONDUCT AT INARI MEDICAL, INC. (NARI)

Newsfile October 14, 2024

Shareholder Alert: Grabar Law Office Is Investigating Claims on Behalf of Long-Term Holders of Inari Medical, Inc. (NARI)

Newsfile October 8, 2024

Inari Medical to Host Analyst and Investor Meeting Following PEERLESS RCT Presentation

GlobeNewswire October 7, 2024

Inari Medical to Announce Third Quarter 2024 Financial Results

GlobeNewswire October 7, 2024

Grabar Law Office Is Investigating Claims on Behalf of Inari Medical, Inc. (NARI) Shareholders

Newsfile September 30, 2024

Inari Medical, Inc. (NARI) Shareholder Notice: Grabar Law Office Is Investigating Claims on Your Behalf

Newsfile September 20, 2024

Kaskela Law LLC Announces Shareholder Investigation of Inari Medical, Inc. (NASDAQ: NARI) and Encourages Investors to Contact the Firm

Business Wire September 17, 2024

Notice to Long-Term Inari Medical, Inc. (NARI) Shareholders

Newsfile September 9, 2024

Grabar Law Office Is Investigating Claims on Behalf of Current Long-Term Shareholders of Inari Medical, Inc. (NARI)

Newsfile September 6, 2024

Inari Medical Announces PEERLESS Data to be Presented During the Late-Breaking Clinical Trial Sessions at TCT 2024

GlobeNewswire August 29, 2024

Inari Medical to Present at Upcoming Investor Conferences

GlobeNewswire August 21, 2024